908 Devices Inc Ordinary Shares MASS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
-
908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
-
908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
-
908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
Trading Information
- Previous Close Price
- $3.48
- Day Range
- $3.43–3.57
- 52-Week Range
- $3.36–12.51
- Bid/Ask
- $3.49 / $3.66
- Market Cap
- $121.30 Mil
- Volume/Avg
- 116,044 / 194,856
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.18
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 230
- Website
- https://www.908devices.com
Comparables
Valuation
|
Metric
|
MASS
|
CNMD
|
CYRX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 17.85 | — |
Price/Book Value | 0.78 | 2.33 | 1.05 |
Price/Sales | 2.18 | 1.64 | 1.72 |
Price/Cash Flow | — | 11.33 | — |
Price/Earnings
MASS
CNMD
CYRX
Financial Strength
|
Metric
|
MASS
|
CNMD
|
CYRX
|
|---|---|---|---|
Quick Ratio | 4.07 | 1.01 | 7.80 |
Current Ratio | 5.09 | 2.34 | 8.38 |
Interest Coverage | — | 4.20 | −31.95 |
Quick Ratio
MASS
CNMD
CYRX
Profitability
|
Metric
|
MASS
|
CNMD
|
CYRX
|
|---|---|---|---|
Return on Assets (Normalized) | −13.36% | 5.07% | −4.69% |
Return on Equity (Normalized) | −16.56% | 14.10% | −9.71% |
Return on Invested Capital (Normalized) | −20.05% | 8.09% | −4.38% |
Return on Assets
MASS
CNMD
CYRX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Lwmkxpdfm | Chldpy | $196.0 Bil | |||
| Stryker Corp
SYK
| Wzlddswpl | Rvmlb | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Vgkvzlpx | Zxpmzy | $124.5 Bil | |||
| Medtronic PLC
MDT
| Fctmtjpg | Lynzszb | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Hqgpdgqh | Kpxcyd | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Xknq | Dnwfh | $30.2 Bil | |||
| DexCom Inc
DXCM
| Vzkpjrnt | Zvfy | $27.3 Bil | |||
| Steris PLC
STE
| Wptrycw | Qjdslt | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Swqrwklxp | Hshy | $21.3 Bil | |||
| Insulet Corp
PODD
| Xhwwhrck | Ymspmz | $16.1 Bil |
United States